Kidney endpoints: the FLOW composite, eGFR slope as an endpoint, albuminuria regression, and why an early eGFR dip is expected rather than alarming.
My eGFR is 92 and has been for years, which I had taken to mean my kidneys were not a topic. A urine albumin:creatinine ratio was added to a recent panel and came…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I want to know whether there is evidence behind this or only…
I am reading the trial table rather than the press release, which is why the numbers differ. I can predict the outcome but I cannot explain it, which means I will get…
FLOW tested semaglutide 1.0 mg in people with type 2 diabetes and chronic kidney disease, and reported a hazard ratio of 0.76 for its composite kidney endpoint. I…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I would like help reading this properly rather than being told…
The clinician who ordered the panel was not concerned; I would still like to understand it. This is not behaving the way I expected and I want to understand the…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
I have three data points across nine months, which I hope is enough to see a trend. This is presented as though it settles something, and I am not convinced it does.…
I am reading the trial table rather than the press release, which is why the numbers differ. I want to understand what this actually establishes, as opposed to what…
HPLC purity, identity confirmation and quantified content on the vial you actually hold. Reports arrive with the chromatogram attached, not just a number.
Submit a sampleFounded 1998. ISO 9001 and cGMP certified, 1,500+ staff and 200+ patents. The synthesis house behind a great many of the vials that get sent out for testing - batch-specific documentation with every order.
Visit GL Biochem